2022 ASM Program

ANZSN Annual Scientific Meeting Provisional Program

17th – 19th October 2022

Monday, 17th October 2022
0800-0830 Registration & Networking
0830 – 1000 PLENARY #1 Gold Members Room
0830-0900 Opening President’s Welcome Welcome to Country Welcome to Delegates
0900-1000 Plenary Speaker GENETIC LANDSCAPES IN THE KIDNEY Professor Katalin Susztak
1000 – 1030 \| Posters & Morning Tea in the Exhibition
1030 – 1200 CONCURRENT SESSION #1
TIME	Symposium Cardiovascular Update	Symposium Transplantation Update	Mini Orals Haemodialysis & General Nephrology	Mini Orals Transplantation & General Nephrology
	Gold Members Room	Platinum Members Room	Ambassadors Room	Olympians Room
1030 – 1100	CARDIAC MRI IN THE CKD Dr Rebecca Kozor	DEALING WITH THE FAILING ALLOGRAFT Professor Bobby Chacko	OSTEOARTHRITIS IN PRECLINICAL CHRONIC KIDNEY DISEASE Nandita Ram	LOWER ACCESS TO AND POORER OUTCOMES OF KIDNEY TRANSPLANT AMONG ABORIGINAL AND TORRES STRAIT ISLANDER CHILDREN AND YOUNG ADULTS: RESULTS FROM THE ANZDATA REGISTRY A/Professor Swasti Chaturvedi
			FEASIBILITY OF ELECTRONIC PATIENT REPORTED OUTCOME MEASURES WITH FEEDBACK OF SYMPTOM MONITORING TO KIDNEY TEAM VIA ANZDATA REGISTRY: THE SWIFT PILOT STUDY Dr Neeru Agarwal	ACCESS AND EQUITY IN TRANSPLANTATION (ASSET) NEW ZEALAND: PROTOCOL FOR POPULATION-WIDE DATA LINKAGE PLATFORM TO INVESTIGATE EQUITY IN ACCESS TO KIDNEY FAILURE HEALTH SERVICES IN NEW ZEALAND Rachel Cutting
			MEDIUM-CUT OFF HEMODIALYSIS WITH THERANOVA DIALYZER AS AN ALTERNATIVE TO HEMODIAFILTRATION: A PROSPECTIVE COHORT STUDY Dr Nuha Ibrahim	LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION IN AN IMMUNOSUPPRESSED RENAL TRANSPLANT RECIPIENT DURING A MOUSE PLAGUE Dr Sanjana Dang
			QUANTIFYING MEANINGFUL AND RELEVANT OUTCOMES OF CARE IN KIDNEY DISEASE: THE PERSONAL BURDEN OF DIFFERENT TREATMENT PATHWAYS Professor Matthew Jose	IMPACT OF MENTAL ILLNESS ON POST-TRANSPLANTATION OUTCOMES IN NEW ZEALAND: THE ASSET-MH DATA LINKAGE STUDY Dr Nicole De La Mata
1100 – 1130	NEW INSIGHTS INTO VASCULAR CALCIFICATION Dr Cynthia St Hilaire	AKX UPDATE Dr Stella McGinn	Mini Oral withdrawn	SELF EMPOWERMENT OF INDIGENOUS AUSTRALIANS WITH RENAL FAILURE TO ASK THEIR DOCTORS “AM I ON THE KIDNEY TRANSPLANT WAITING LIST?” A/Professor David Goodman
			ASSOCIATION BETWEEN METABOLIC-DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) OR ADVANCED LIVER FIBROSIS AND CARDIOVASCULAR DISEASES AMONG HEMODIALYSIS PATIENTS Dr Wei Kei Wong	COST-EFFECTIVENESS OF INTERVENTIONS TO INCREASE UTILIZATION OF KIDNEYS FROM DECEASED DONORS WITH PRIMARY BRAIN MALIGNANCY James Hedley
			AGREEMENT ON THE CLINICAL ADJUDICATION OF CATHETER-RELATED INFECTIOUS EVENT REPORTING AMONG AUSTRALIAN AND NEW ZEALAND KIDNEY SERVICES Jayson Catiwa	REAL WORLD EXPERIENCE OF SOTROVIMAB IN RENAL TRANSPLANT RECIPIENTS WITH MILD-MODERATE COVID-19 INFECTION Dr Daniel Hirsch
			MULTIFACETED INTERVENTIONS TO PREVENT HAEMODIALYSIS CATHETER-RELATED BLOODSTREAM INFECTIONS OUTSIDE THE INTENSIVE CARE UNIT: A SYSTEMATIC REVIEW AND META-ANALYSIS Dr Benjamin Lazarus	THE RISK FACTORS FOR MORTALITY WITHIN FIRST YEAR AND THREE YEAR AFTER KIDNEY TRANSPLANTATION Dr Nusa Purnawan Putra
1130 – 1200	CARDIAC FIBROSIS IN PRE-CLINICAL MODELS OF CHRONIC KIDNEY DISEASE AND RELEVANCE TO HUMANS Professor Rob Walker	THE PROMISE OF CELL THERAPY IN TRANSPLANTATION Dr Jennifer Li	GOING WITH THE FLOW: PREDICTING HIGH FLOW ARTERIOVENOUS FISTULAS AND CARDIOVASCULAR OUTCOMES IN HAEMODIALYSIS PATIENTS Dr Nasir Shah	CAN MICROSAMPLING METHODS REPLACE VENEPUNCTURE FOR SIMULTANEOUS THERAPEUTIC DRUG MONITORING OF TACROLIMUS, MYCOPHENOLIC ACID AND PREDNISOLONE CONCENTRATIONS IN ADULT KIDNEY TRANSPLANT PATIENTS? Carla Scuderi
			DEVELOPMENT OF A DEEP LEARNING ALGORITHM CAPABLE OF IDENTIFYING KIDNEY BIOPSY STRUCTURES WITH HIGH FIDELITY Dr Daniel Christiadi	POST KIDNEY TRANSPLANT HYPERCALCAEMIA AND PERSISTING HYPERPARATHYROIDISM IN THE CURRENT ERA Dr Jocelyn Shan
			MODELLING FABRY DISEASE WITH INDUCED PLURIPOTENT STEM CELL-DERIVED PODOCYTES Dr Shoni Bruell	TEMPORAL TRENDS IN THE INCIDENCE OF GENERAL SURGERY AND POSTOPERATIVE MORTALITY IN 46, 707 PATIENTS RECEIVING CHRONIC KIDNEY REPLACEMENT THERAPY IN AUSTRALIA AND NEW ZEALAND FROM 2000 TO 2015 Dr Dharmenaan Palamuthusingam
1200 – 1300 \| Posters & Lunch in the Exhibition
1300 – 1500 \| PLENARY #2: YOUNG INVESTIGATOR AWARD Gold Members Room
The 2022 Young Investigator Award is proudly supported by the ASM’s Platinum Partners AstraZeneca and Fresenius Medical Care
BASIC SCIENCE
MONK CONTROLS DEVELOPMENT OF GLOMERULONEPHRITIS AND REGULATES B CELL AUTOREACTIVITY Tom Lea-Henry
GASDERMIN-D MUTATION IS PROTECTIVE AGAINST RENAL ISCHEMIA REPERFUSION INJURY Dr Jennifer Li
SUBPOPULATIONS OF LYMPHOCYTES IN LONG SURVIVING RENAL TRANSPLANT PATIENTS COMPARED TO HEALTHY VOLUNTEERS Prateek Rakesh
LIRAGLUTIDE INDUCED PRE-CONCEPTION WEIGHT LOSS IMPROVES FERTILITY AND METABOLIC INFLAMMATION IN OBESE MICE AND ALTERS KIDNEY OUTCOMES FOR THE OFFSPRING Dr Natassia Rodrigo
CLINICAL SCIENCE
SHOULD I HAVE A TRANSPLANT? USING FLEXIBLE PARAMETRIC MODELS TO PREDICT SURVIVAL AFTER KIDNEY TRANSPLANT WAITLISTING Dr Georgina Irish
EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISONE IN IGA NEPHROPATHY: THE TESTING TRIAL Dr Dana Kim
PREVENTION OF HAEMODIALYSIS CATHETER DYSFUNCTION: POST-HOC ANALYSIS OF A NATIONAL STEPPED-WEDGE CLUSTER RANDOMIZED TRIAL Dr Benjamin Lazarus
CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL Dr Brendon Neuen
1500 – 1530 \| Posters & Afternoon Tea in the Exhibition
1530 – 1700 CONCURRENT SESSION #2
	Symposium Diabetic Kidney Disease	Symposium AKTN Update	Mini Orals Health Services Research & General Nephrology	Mini Orals Environmental Sustainability, Acute Kidney Injury & Glomerulonephritis
	Gold Members Room	Platinum Members Room	Ambassadors Room	Olympians Room
1530-1600	RESOLVING INFLAMMATION AND SUPPRESSING FIBROSIS IN THE VASCULAR COMPLICATIONS OF DIABETES Professor Catherine Godson	INTRODUCTION A/Professor Matthew Roberts UPDATE ON AKTN ACTIVITIES Professor David Johnson	MODELS OF CARE TO ADDRESS DISPARITIES IN KIDNEY HEALTH OUTCOMES FOR FIRST NATIONS PEOPLES: A SYSTEMATIC REVIEW Dr Samantha Bateman, Kelli Owen	THE CLIMATE FOOTPRINT OF PLANT BASED DIETS FOR CKD VS USUAL CARE: WHICH IS BETTER FOR THE PLANET? Dr Kelly Lambert
			INFORMING THE EVIDENCE-PRACTICE GAP ABOUT FRAILTY-SUPPORT FOR ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE WITH END STAGE KIDNEY DISEASE: THE ‘FRAILTY TO FIT’ PILOT STUDY Richard Modderman	WATER REUSE AND WASTE REDUCTION IN DIALYSIS: A SCOPING REVIEW Georgina MacPherson
		THE PHOSPHATE TRIAL – HIGH OR STANDARD PHOSPHATE TARGETS IN KIDNEY FAILURE Professor Suetonia Palmer	PRIORITISING FIRST NATIONS VOICES IN KIDNEY RESEARCH – THE TOP END MEDICINAL IRON RESEARCH & STUDY ADVISORY GROUP Stephanie Long	A COMPARISON OF ENVIRONMENTAL SUSTAINABILITY PRACTICES BETWEEN URBAN AND REGIONAL DIALYSIS UNITS IN AUSTRALIA Dr Ben Talbot
			THE ELDERLY ADVANCED CKD PROGRAM: METHODS & BASELINE CHARACTERISTICS OF A STUDY PROGRAM INVESTIGATING TREATMENT DECISION-MAKING & CARE AMONG OLDER ADULTS WITH KIDNEY FAILURE Dr Martin Gallagher	UPREGULATION OF THE AP-1 PATHWAY IN SYSTEMIC LUPUS ERYTHEMATOSIS Dr Prasanti Kotagiri
1600-1630	THE BEGINNING OF THE END? LESSONS FROM STUDYING YOUTH WITH AND AT HIGH RISK OF DKD Professor Josephine Forbes		INDIGENOUS PEOPLES’ PERSPECTIVES OF LIVING WITH CHRONIC KIDNEY DISEASE: SYSTEMATIC REVIEW OF QUALITATIVE STUDIES Marianne Kerr	INCIDENCE AND OUTCOMES OF RENAL ADVERSE EVENTS FOLLOWING TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS Jessica Maccan
			UNDERSTANDING THE EVIDENCE BASE ON THE MANAGEMENT OF CHRONIC KIDNEY AMONG FIRST AND SOVEREIGN PEOPLES TO DEVELOPING GUIDELINES RECOMMENDATIONS FOR CLINICAL CARE Dr David Tunnicliffe	CARDIORENAL SYNDROME IN COVID-19 PATIENTS: A SYSTEMATIC REVIEW Ling Lin
		THE REMIT TRIAL IN MEMBRANOUS NOPHROPATHY Dr Bhadran Bose	CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE Associate Professor Rathika Krishnasamy	NEPHROLOGY INTERVENTION IN PATIENTS WAITING FOR CARDIAC SURGERY: A RANDOMIZED CLINICAL TRIAL Laia Oliveras
			TERRITORY KIDNEY CARE (TKC): AN INNOVATIVE DIGITAL PLATFORM SUPPORTING INTEGRATED CHRONIC DISEASE CARE Dr Asanga Abeyaratne	THE RELATIONSHIP BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT IN PATIENTS WITH ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS Ajinkya Bhonsle
1630-1700	BIOMARKERS IN DKD Professor Peter Rossing	INNOVATIONS & ADAPTIONS – MOVING FORWARD Professor Carmel Hawley	LESSONS LEARNT FROM THE 2022 NORTHERN NSW FLOODS EXPERIENCE Dr Victoria Sasongko	T CELL COSTIMULATORY BLOCKADE WITH CTLA4-IG AMELIORATES HEYMANN NEPHRITIS VIA TH17 SUPPRESSION IN THE KIDNEY INDEPENDENT OF AUTOANTIBODY PRODUCTION Dr Edmund Chung
			A NOVEL ELECTRONIC SURVEILLANCE PROGRAM TO TRACK BLOODSTREAM INFECTIONS IN HAEMODIALYSIS PATIENTS (SPOT-BSI) Dr Benjamin Lazarus	INTERFERON STIMULATED GENES ARE UPREGULATED IN MPO-AAV Dr Prasanti Kotagiri
		PANEL DISCUSSION	LONGITUDINAL EVALUATION OF SELF-REPORTED MOBIITY IMPAIRMENT IN END-STAGE KIDNEY DISEASE Thai Binh Tran	PERSONALISED MEDICINE IN THE MANAGEMENT OF GLOMERULONEPHRITIS Dr Giles Walters
1700-1800	AGM \| Gold Members Room
1700-1930	Poster Session & Welcome Reception \| Exhibition Lounge
ASM Day 1 Concludes

Tuesday, 18th October 2022
0800-0830 Registration & Networking
REVISED PROGRAM
0830 – 1000 CONCURRENT SESSION #3
TIME	Award Session Basic Science	Award Session Shaun Summers Clinical Trainee	Symposium Interventional Nephrology	Mini Orals Diabetes/Cardiovascular/Hypertension & Epidemiology and Public Health
	The *2022 Basic Science* and *Clinical Trainee Awards* are proudly supported by the ASM’s Gold Partners *Amgen, Baxter, GSK, Bayer, Pharmacor* and *CSL Vifor*
	Gold Members Room	Platinum Members Room	Ambassadors Room	Olympians Room
0830 – 0845	A HIGH-THROUGHPUT MULTIPLEX REPORTER ASSAY SYSTEM TO RAPIDLY SCREEN GENETIC VARIANTS CONTRIBUTING TO CHRONIC KIDNEY DISEASE (CKD) IN INDIGENOUS COMMUNITIES Dr Vicki Athanasopoulos	MANAGEMENT OF PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): A CLINICAL AUDIT Dr Laura Cuthbertson RENAL OUTCOMES AND RENAL REPLACEMENT THERAPY POST CARDIAC TRANSPLANTATION Dr Masnun Kayes A SINGLE CENTRE STUDY OF ADMITTED PATIENTS WITH FRAGILITY FRACTURES IN DIALYSIS PATIENTS, OUTCOMES AND CKD-MBD FOLLOW-UP Dr Louise Keamy	PD INSERTION TECHNIQUES AND EXPERIENCES Dr Jan John Swinnen, Dr Murty Mantha and Dr David Voss	AORTIC CALCIFICATION IN ADENINE-INDUCED RAT MODELS OF CHRONIC KIDNEY DISEASE Sean A Barton
				SPLEEN TYROSINE KINASE DELETION IN MYELOID CELLS REDUCES GLOMERULAR MACROPHAGE INFILTRATION AND GLOMERULOSCLEROSIS IN DIABETIC MICE Dr Xiu Xian Chia
0845 – 0900	COMBINED NICOTINAMIDE RIBOSIDE (NR) AND MITOCHONDRIAL TARGETED ANTIOXIDANT SKQR1 PROVIDES NEPHROPROTECTION IN RODENT ISCHAEMIA-REPERFUSION INJURY (IRI) IN SUBCLINICAL CHRONIC KIDNEY DISEASE (sCKD) Dr Sanjeeva Herath			POST-EXERCISE AUTONOMIC FUNCTION AS A PREDICTOR OF LONG-TERM ESTIMATED GLOMERULAR FILTRATION RATE IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE Dr Camila Eleuterio Rodrigues
				A PILOT EXAMINATION OF TEMPORAL CHANGES IN EARLY KIDNEY FUNCTION IN YOUTH WITH TYPE 1 DIABETES USING EGFR SLOPE Professor Josephine Forbes
0900 – 0915	HUMAN PROXIMAL TUBULAR EPITHELIAL CELL (PTEC)-DERIVED APICAL SMALL EXTRACELLULAR VESICLES (sEV) MEDIATE A ‘WAVE OF DEATH’ IN HYPOXIC CHRONIC KIDNEY DISEASE (CKD) Dr Andrew Kassianos	CASE SERIES: BELIMUMAB IN REFRACTORY LUPUS NEPHRITIS Dr Aruni Malaweera FACTORS ASSOCIATED WITH DIALYSIS WITHDRAWAL FOLLOWING MODALITY CHANGE FROM PERITONEAL DIALYSIS TO HAEMODIALYSIS: AN AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY ANALYSIS, 2004-2019 Dr Sarah Tan PATIENT SURVIVAL AND PROBABILITY OF RE-TRANSPLANTATION BY DIALYSIS MODALITY FOLLOWING KIDNEY ALLOGRAFT FAILURE – AN ANZDATA REGISTRY COHORT STUDY Thiveya Theivendran	PROBLEM SOLVING PERMACATHS Dr Mahmoud Amer	MITOCHONDRIAL DYSFUNCTION ALIGNS WITH RISK FOR DIABETIC KIDNEY DISEASE IN YOUTH WITH TYPE 1 DIABETES Dr Mitchell Sullivan
				EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA, WITH AND WITHOUT DIABETES, BY USE AND NON-USE OF CARDIOVASCULAR MEDICATIONS: DAPA-CKD TRIAL Professor Ricardo Correa-Rotter
0915 – 0930	STRATEGIES TO PREVENT ACUTE KIDNEY INJURY AND INTERVENE TO IMPROVE RENAL RECOVERY Professor David Nikolic-Paterson			EPIDEMIOLOGY OF FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS IN INDIGENOUS AND NON-INDIGENOUS AUSTRALIANS Dr Elisa Bongetti
				INFECTION-RELATED MORTALITY IN ADULTS TREATED WITH MAINTENANCE DIALYSIS Dr Chanel Chong
0930 – 0945	HYPOXIA TRIGGERS A SIGNATURE OF MALADAPTIVE REPAIR IN HUMAN KIDNEY ORGANOIDS Ana Nunez-Nescolarde	BURDEN OF INFECTION-RELATED HOSPITALISATION AND THE IMPACT OF MULTIDISCIPLINARY CARE IN ANCA ASSOCIATED VASCULITIS: A RETROSPECTIVE COHORT Emily Yeung SURGICAL COMPLICATIONS AND OUTCOMES IN OBESE RENAL TRANSPLANT RECIPIENTS Dr Theodora Yiu	WHY YOU SHOULD BE AN INTERVENTIONALIST Dr Steve May	PREDICTING THE FUTURE: MODELLING FUTURE PREVALENCE OF AUSTRALIAN DIALYSIS PATIENTS: 2021-2030 Dr Christopher Davies
				TRENDS IN CARDIAC SURGERY FOR DIALYSIS AND TRANSPLANT PATIENTS 2001-2019: AN AUSTRALIAN DATA LINKAGE STUDY Dr Dominic Keuskamp
0945 – 1000	ROLE OF COMPLEMENT C5A RECEPTOR 1 (CA5R1) IN MODULATING CELLULAR SENESCENCE IN DIABETIC KIDNEY DISEASE Dr Sih Min Tan			COMPARING THE OUTCOMES EXPERIENCED IN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR KIDNEY OUTCOME TRIALS TO A CANADIAN CHRONIC KIDNEY DISEASE COHORT Dr Tae Won Yi
		0945
1000 – 1030 \| Posters & Morning Tea in the Exhibition
1030 -1130 PLENARY #3 Gold Members Room
1030 – 1130 Plenary Speaker KLOTHO, PHOSPHATE AND FGF23 Professor Orson W. Moe
1130 – 1300 \| Posters & Lunch in the Exhibition
1300 – 1400 \| PLENARY #4: Consumer Session
Speakers and panellists include; Dr Brooke Huuskes Professor Allison Jaure Dr Hugh McCarthy Ieyesha Roberts Dr Sharon Ford Catherine Keegan
1400 – 1410 Move to breakouts
1410 – 1515 CONCURRENT SESSION #4
TIME	Mini Orals Peritoneal Dialysis	Mini Orals Paediatrics	Mini Orals Nutrition & Interventional Nephrology	Mini Orals Developmental Biology, Experimental Immunology & Genetics
	Gold Members Room	Platinum Members Room	Ambassadors Room	Olympians Room
1415 – 1515	LONG TERM IMPACT OF EARLY NON-INFECTIOUS COMPLICATIONS AT THE INITIATION OF PERITONEAL DIALYSIS Dr Raymond Chan	OUTCOMES OF KIDNEY REPLACEMENT THERAPY IN CHILDREN WITH ACUTE KIDNEY INJURY Marc Chami	ACCEPTABILITY, ADHERENCE, AND SAFETY OF LOW ENERGY DIETS FOR OBESITY MANAGEMENT IN CHRONIC KIDNEY DISEASE: A MIXED METHODS STUDY Marguerite Conley	IGF FATTENS GROWING KIDNEY CELLS Dr Soon Wei Wong
	FREQUENCY AND RISK FACTORS FOR COGNITIVE DYSFUNCTION IN PERITONEAL DIALYSIS PATIENTS Dr Isuru Gamage	CORRECTING HYPERNATRAEMIA IN CHILDREN – THE CHIC STUDY Dr Madeleine Didsbury	THE PREVALENCE OF FRAILTY AND MALNUTRITION AND ASSOCIATION WITH DIETARY INTAKE IN PEOPLE COMMENCING A CONSERVATIVE KIDNEY MANAGEMENT PATHWAY Dr Jessica Dawson	NLRP3 INFLAMMASOME ACTIVATION IS INCREASED IN POLYCYSTIC KIDNEY DISEASE AND IS A KEY DRIVER OF CYST PROGRESSION Jemma Gasperoni
	ASSOCIATION OF INCREMENTAL PERITONEAL DIALYSIS WITH RESIDUAL KIDNEY FUNCTION DECLINE IN PATIENTS ON PERITONEAL DIALYSIS: THE balANZ TRIAL Dr Ashik Hayat	LONGITUDINAL ASSESSMENT OF THE HEALTH-RELATED QUALITY OF LIFE OF CHILDREN AND ADOLESCENTS WITH CHRONIC KIDNEY DISEASE Chandana Guha	INFLUENCE OF FRAILTY AND MALNUTRITION ON 2 YEAR SURVIVAL OF PATIENTS WITH ADVANCED KIDNEY FAILURE Dr Jessica Dawson	HIGH PREVALENCE, BUT SUBOPTIMAL CANCER SCREENING: MANAGING BIRT-HOGG-DUBE SYNDROME (BHD) IN TASMANIA, AUSTRALIA Dr Laura Cuthbertson
	EXPLORING PRECONCEPTIONS IN CHOOSING PERITONEAL DIALYSIS (PD) – PD MYTHS STUDY Dr Saskia Leibowitz	EFFECT OF ANGIOTENSIN II TYPE 1 RECEPTOR (AT1R) ANTIBODIES ON GRAFT FUNCTION AND SURVIVAL IN PAEDIATRIC KIDNEY TRANSPLANT RECIPIENTS Dr Rachael Kermond	EFFECT OF NUTRITIONAL CALCIUM AND PHOSPHATE LOADING ON CALCIPROTEIN PARTICLE KINETICS IN ADULTS WITH NORMAL AND IMPAIRED KIDNEY FUNCTION Dr Mark Tiong	PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) Dr Sayanthooran Saravanabavan
	INCIDENCE AND TREATMENT OF PERITONITIS DUE TO ROTHIA SPECIES IN PATIENTS ON PERITONEAL DIAYSIS IN AUSTRALIA AND NEW ZEALAND Chau Wei Ling	BEHAVIOURAL AND PSYCHOSOCIAL OUTCOMES IN CHILDREN WITH CHRONIC KIDNEY DISEASE: THE KIDS WITH CKD (KCAD) STUDY Campbell Drohan	OUTLINING THE NUMBERS: TUNNELLED HAEMODIALYSIS CATHETER REMOVALS BY THE RENAL DEPARTMENT Dr Andrea Huang	EXPERIENCES OF PARTICIPANTS ENROLLED IN A RANDOMISED CONTROLLED TRIAL OF PRESCRIBED WATER INTAKE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Dr Sayanthooran Saravanabavan
	CLINICAL OUTCOMES OF PATIENTS WITH KIDNEY FAILURE TREATED WITH INCREMENTAL PERITONEAL DIALYSIS Mary Ann Nicdao	LIFE PARTICIPATION IN CHILDREN WITH CHRONIC KIDNEY DISEASE – A COHORT STUDY Adam Hudson	LOW-DOSE HYDRALAZINE ATTENUATES OBESITY-RELATED CHRONIC KIDNEY DISEASE AND NORMALISES RENAL DNA METHYLATION IN MICE Dr Long The Nguyen	ELUCIDATION AND TREATMENT OF ITK MEDIATED AUTOIMMUNITY THROUGH PERSONALISED MEDICINE Maurice Stanley
	COSTS OF INCREMENTAL AND FULL-DOSE PERITONEAL DIALYSIS: A MICRO-COSTING ANALYSIS Mary Ann Nicdao	PREVALENCE, CORRELATES AND OUTCOMES OF GLOMERULAR HYPERFILTRATION IN CHILDREN WITH CANCER Dr Blake Sandery	‘ESCAPE’ END-CUT VS. SIDE-CUT NEEDLES FOR PERCUTANEOUS RENAL BIOPSY: PRECLINICAL PORCINE STUDY A/Prof Tim Spicer	A GENETIC MODIFIER OF MALARIA AND DISTAL RENAL TUBULAR ACIDOSIS: A CASE REPORT OF A PATIENT WITH A FILIPINO FOUNDER VARIANT IN SLC4A1 Hope Tanudisastro
1515 – 1545 \| Posters & Afternoon Tea in the Exhibition
1545 – 1715 CONCURRENT SESSION #5
TIME	Award Session Kidney Health Australia Clinical Science	Symposium Tubules behaving badly	Symposium First Nations health care in Nephrology	Mini Orals General Nephrology, Pregnancy Associated & Experimental Tuboloinstertitial Disease
	Gold Members Room	Platinum Members Room	Ambassadors Room	Olympians Room
1545 – 1600	ASSOCIATIONS BETWEEN LOW GDP PERITONEAL DIALYSIS SOLUTIONS WITH PERITONITIS, TRANSFER TO HAEMODIALYSIS, AND PATIENT SURVIVAL Dr Jenny Chen	URIC ACID AND STONE FORMATION Professor Orson W. Moe	CARI GUIDELINES Dr David Tunnicliffe, Rhanee Lester	CONVOLUTIONAL NEURAL NETWORK-BASED IMMUNOFLUORESCENCE IMAGE CLASSIFICATION OF KIDNEY BIOPSIES Xiuxiu Hu
				IDENTIFYING BIOCHEMICAL CHANGES IN THE KIDNEY USING NUCLEAR MAGNETIC RESONANCE IN AN ADENINE-DIET CHRONIC KIDNEY DISEASE MOUSE MODEL Tyrone Humphries
1600 – 1615	RAPID RISE IN CHRONIC KIDNEY DISEASE IN RURAL AND REMOTE COMMUNITIES Professor Matthew Jose			LITHIUM-ASSOCIATED END STAGE KIDNEY DISEASE: PREDICTORS AND OUTCOMES Dr Emily Qian
				CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS WITH OSTEOPOROTIC HIP FRACTURE: PREVALENCE, CLINICAL PROFILE, OUTCOMES AND MANAGEMENT CHALLENGES Dr Jo-Wai Douglas Wang
1615 – 1630	INTENSIVE CARE ADMISSIONS FOR DIALYSIS AND TRANSPLANT PATIENTS 2018-2020: AN AUSTRALIAN DATA LINKAGE STUDY Dr Dominic Keuskamp	MITOCHONDRIAL DEFECTS Professor Katalin Susztak	KIDNEY HEALTH IN INDIGENOUS CHILDREN Associate Professor Swasti Chaturvedi	ASSOCIATIONS BETWEEN URAEMIC TOXINS, SYMPTOMS AND THE GUT MICROBIOME IN ADVANCED CHRONIC KIDNEY DISEASE Philippa James
				OBSTETRIC (LABOUR AND DELIVERY) PATTERNS AND OUTCOMES IN MOTHERS RECEIVING DIALYSIS OR WITH A KIDNEY TRANSPLANT Dr Nishanta Tangirala
1630 – 1645	TUNNELLED CENTRAL VENOUS HAEMODIALYSIS CATHETER TIP DESIGN AND RISK OF CATHETER DYSFUNCTION Dr Benjamin Lazarus			PHOTOBIOMODULATION ALLEVIATES CHRONIC KIDNEY DISEASE VIA SUPPRESSION OF INFLAMMATION AND OXIDATIVE STRESS Dr Ji Bian
				HYPOXIA AND INTERLEUKIN (IL)-1β SENSITISE PROXIMAL TUBULE EPITHELIAL CELLS (PTEC) TO TRANSFORMING GROWTH FACTOR (TGF)-β SIGNALLING Kurt TK Giuliani
1645 – 1700	RISK FACTORS AND OUTCOMES OF COVID-19 IN RENAL TRANSPLANT RECIPIENTS IN SOUTH WESTERN SYDNEY LOCAL HEALTH SYDNEY DURING THE 2021-2022 PANDEMIC PERIOD Dr Daniela Potter	HYPOXIA + HIF1a Professor Tetsuhiro Tanaka	CHALLENGES IN EQUITY OF ACCESS IN FIJI Dr Amrish Krishnan	INTERVENTION WITH SENOLYTIC AND SENOSTATIC DRUGS SUPPRESSES THE PROGRESSION OF TUBULOINTERSTITIAL FIBROSIS IN DIABETIC MICE Professor David Nikolic-Paterson
				IDENTIFICATION AND QUANTIFICATION OF MATRISOME PROTEINS IN MOUSE KIDNEYS Umut Rende
1700 – 1715	ACADEMIC ACHIEVEMENT AMONG CHILDREN WITH CHRONIC KIDNEY DISEASE (CKD) IN THE NATIONAL ASSESSMENT PROGRAM – LITERACY AND NUMERACY (NAPLAN): LONGITUDINAL DATA FROM THE KIDS WITH CKD (KCAD) STUDY Dr Anita Van Zwieten			EXAMINING URINARY EXFOLIATED PROXIMAL TUBULE CELLS BY MORPHOLOGY – DEEP LEARNING IMAGING CELLS (RELIC) TO ASSESS KIDNEY PATHOLOGY A/Professor Sonia Saad

1715	Tuesday Sessions Conclude
1900	Gala Dinner & Awards \| Field of Play & Gold Members Room, Accor Stadium
ASM Day 2 Concludes

Wednesday, 19th October 2022
0730 – 0800 Registration & Networking
0800 – 0900 PLENARY #3 Gold Members Room
0800 – 0900 Plenary Speaker KLOTHO, PHOSPHATE AND FGF23 Professor Orson W. Moe
0900 – 1030 CONCURRENT SESSION #6
TIME	Symposium ANZDATA	Symposium End of life care: symptom management, decision making and VAD	Symposium Paediatrics	Symposium Pathophysiology in kidney disease – inside and out
	Gold Members Room	Platinum Members Room	Ambassadors Room	Olympians Room
0900 – 0930	Presentations from the following: Dr Nicholas Gray Professor Stephen McDonald Dr Sradha Kotwal Dr Dominic Keuskamp Dr Georgina Irish Dr Adam Steinberg Followed by Q&A	Presentations from the following: Dr Frank Brennan Dr Kathryn Ducharlet A/Prof Leeroy William Dr Dan Fleming Dr Greg Mewett Dr Margaret Fraenkel Natalie Wester Followed by Q&A	WHAT CAN WE LEARN FROM KIDNEY ORGANOIDS Dr Tom Forbes	METABOLIC BONE DISEASE IN RENAL FAILURE Sinee Disthabanchong
0930 – 1000			COGNITION IN CKD Dr Siah Kim	LINKING BASEMENT MEMBRANE BIOLOGY TO HUMAN KIDNEY DISEASE Prof Rachel Lennon
1000 – 1030			NOVEL THERAPEUTICS IN INHERITED KIDNEY DISEASE Dr Tom Forbes	NEUROLOGICAL DISORDERS IN CKD Prof Ziad A. Massy
1030 – 1100\| Posters & Morning Tea in the Exhibition
1100 – 1230 \| PLENARY #5 Gold Members Room
Equity & Diversity in Nephrology
Panel Discussion Prof Anne Kelso: Funding for health and medical research Dr Magdalena Simonis: Changing workplace culture in the health system Dr Nicki Scholes-Robertson: Care for regional and rural people
1230 – 1300 \| Posters & Lunch in the Exhibition
1300 – 1430 \| PLENARY #6 Gold Members Room
TJ Neale Award Presentation
Jacquot Fellowships and Awards – Research Establishment Dr Katherine Barraclough
Jacquot Fellowships and Awards – Research Entry Dr Amali Mallawaarchchi
Kidney Research Alliance Chris Forbes, Professor Carmel Hawley, A/Professor Tim Hewitson
Closing
ASM Day 3 Concludes

2022 ASM Program

ANZSN Annual Scientific Meeting Provisional Program

17th – 19th October 2022

Monday, 17th October 2022

Tuesday, 18th October 2022

Wednesday, 19th October 2022

ABOUT THE SOCIETY

ACKNOWLEDGEMENT OF COUNTRY